Brain Aging: How Did Menin and D-Serine Help Mice?

What did researchers discover about Menin and memory?

Researchers found that Menin declined with age in the hypothalamus, a brain region involved in regulating bodily functions. Experimentally reducing Menin accelerated aging-related changes, while restoring it in older mice improved cognition and several physical measures. The experiments are described in the [PLOS Biology study](https://doi.org/10.1371/journal.pbio.3002033).

The team also connected Menin to production of D-serine, an amino acid involved in communication between nerve cells. Supplementation improved cognitive performance, but did not reproduce the broader physical benefits of restoring Menin. These were distinct interventions with different effects.

What evidence would be needed before this could help patients?

Animal experiments help researchers identify biological mechanisms and decide which interventions deserve further investigation. They do not establish how an intervention will perform in people. The National Institute on Aging explains that clinical trials test whether interventions are safe and effective in humans, often following laboratory and animal research. Participants receive defined assessments and monitoring under a study protocol. [National Institute on Aging: Clinical trials and studies](https://www.nia.nih.gov/health/clinical-trials-and-studies/what-are-clinical-trials-and-studies).

For a proposed memory treatment, the practical research questions would include whether improvements persist, whether patients notice benefits in everyday activities, and whether adverse effects outweigh those benefits. A suitable comparison group would help distinguish treatment effects from changes that occur without the intervention. These are requirements for interpreting a future treatment claim; they should not be read as evidence that a Menin-directed therapy or D-serine regimen has already met them.

Should older adults take amino acid supplements for memory?

Amino acids can be sold as dietary supplements, but availability does not demonstrate that a product treats cognitive decline. The National Institute on Aging advises discussing supplements with a clinician because they may cause unwanted effects, interact with medicines, or provide no benefit. That distinction matters when an experimental result becomes a consumer-facing claim about brain health. [National Institute on Aging: Dietary supplements for older adults](https://www.nia.nih.gov/health/dietary-supplements).

Before considering a product, discuss its exact ingredients, intended purpose, and compatibility with current medicines. The useful question is whether evidence supports that particular intervention for the particular person taking it. Neither the word amino acid nor a connection to a biological pathway supplies an answer about an effective dose, long-term safety, or clinical benefit.